As AR is the key-driving transcription factor in prostate cancer, tightly controlled by epigenetic regulation, integrating these datastreams has the potency to reveal distinct biological features for a tumor type classically-known as difficult to classify. This evidence concerns the gene AR and prostate carcinoma.